Matt Meyerson headshot

Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Dana Farber Cancer Institute
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Authors: Authors: Dutt A, Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C, Nicoletti R, Winckler W, Grewal R, Hanna M, Wyhs N, Ziaugra L, Richter DJ, Trovik J, Engelsen IB, Stefansson IM, Fennell T, Cibulskis K, Zody MC, Akslen LA, Gabriel S, Wong KK, Sellers WR, Meyerson M, Greulich H.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
A 15-gene expression signature prognostic for survival and predictive for adjuvant chemotherapy benefit in JBR.10 patients.
Authors: Authors: Tsao MS, Zhu C, Ding K, Strumpf D, Pintilie M, Meyerson M, Seymour L, Jurisica I, Shepherd FA.
J Clin Oncol
View full abstract on Pubmed
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
Authors: Authors: Loriaux MM, Levine RL, Tyner JW, Fröhling S, Scholl C, Stoffregen EP, Wernig G, Erickson H, Eide CA, Berger R, Bernard OA, Griffin JD, Stone RM, Lee B, Meyerson M, Heinrich MC, Deininger MW, Gilliland DG, Druker BJ.
Blood
View full abstract on Pubmed
Major copy proportion analysis of tumor samples using SNP arrays.
Authors: Authors: Li C, Beroukhim R, Weir BA, Winckler W, Garraway LA, Sellers WR, Meyerson M.
BMC Bioinformatics
View full abstract on Pubmed
Adding pathogens by genomic subtraction.
Authors: Authors: MacConaill L, Meyerson M.
Nat Genet
View full abstract on Pubmed
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
Authors: Authors: Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin WG.
Genes Dev
View full abstract on Pubmed
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
Authors: Authors: Swanson KD, Winter JM, Reis M, Bentires-Alj M, Greulich H, Grewal R, Hruban RH, Yeo CJ, Yassin Y, Iartchouk O, Montgomery K, Whitman SP, Caligiuri MA, Loh ML, Gilliland DG, Look AT, Kucherlapati R, Kern SE, Meyerson M, Neel BG.
Genes Chromosomes Cancer
View full abstract on Pubmed
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.
Authors: Authors: Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
Authors: Authors: Engelsen IB, Stefansson IM, Beroukhim R, Sellers WR, Meyerson M, Akslen LA, Salvesen HB.
Int J Oncol
View full abstract on Pubmed
Modeling genomic diversity and tumor dependency in malignant melanoma.
Authors: Authors: Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, Laine E, Greulich H, Tseng H, Gates C, Hodi FS, Dranoff G, Sellers WR, Thomas RK, Meyerson M, Golub TR, Dummer R, Herlyn M, Getz G, Garraway LA.
Cancer Res
View full abstract on Pubmed